Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

2012 BIO Investor Forum: Discovery Track Snapshot

cablecar

BIO’s 11th Annual BIO Investor Forum is just around the corner – it will be held October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The forum, or BIF as we call it around here, is an international investor event which explores trends and opportunities in life sciences. Broadly speaking, the focus is on venture-stage growth and emerging public companies. BIO’s Alan Eisenberg said it best earlier this week: “The aim of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Colorado Biotech’s Big Day

biowest

Last week, the Colorado BioScience Association (CBSA) hosted its annual BioWest Conference – a one day event attended by more than 500 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. Colorado Public Radio’s Ryan Warner interviewed CBSA’s April Giles about the conference and several innovative biotech companies in the state. Give it a listen.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

New Report Shows Strength of Massachusetts’ Biotech Industry

arrow

If you read this blog, there’s a good chance you already know that Massachusetts is one of the biggest biotech hubs in the world. The Commonwealth’s successes in biotech economic development can be attributed to a number of things. Perhaps foremost, its world-class universities, such as MIT and Harvard, continue to churn out the innovation that keeps venture groups interested. Meanwhile, established biotechs and Big Pharma continue to focus more and more R&D work in Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Award Honors Rhode Island Biotech Excellence

RI_imagelogo

Know somebody in Rhode Island biotech that deserves special recognition? Then nominate them for Tech Collective’s Rhode Island Bioscience Awards. Check it out, nominate, and apply here. Nominations are due September 24th, Applications are due October 1st.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Massachusetts Governor and Lawmakers Improve Patient Access

Deval-btn

Earlier this week Massachusetts Governor Deval Patrick signed the 2013 budget. Within that budget are two provisions that will ultimately benefit healthcare consumers within the Commonwealth. The first provision was a partial repeal of the Massachusetts gift ban law enacted two years ago. In the words of Governor Patrick, “This narrow change will afford healthcare providers some flexibility to be educated on new clinically relevant products and allow them to stay informed on advancements in Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,